Company Employee - BioTech Funding Portal

Content reflects the views of the posting party and is provided for informational purposes only. It does not constitute a solicitation, recommendation, endorsement, or investment advice by BioTech Funding Portal. All content is subject to the portal’s Community Content Guidelines.

Jay Hunt

National Director, Field Medical Oncology

EMD Serono

Oncology expert: 42 yrs cancer research, 21 yrs pharma med affairs; publications, trials, lifecycle mgmt, KOL ties, leadership, strong comms View (0) Answers

Ask a Question

Lee-Ann Murphy

Corporate Affairs and Product Communications Professional

Freelance

Biotech communications advisor with 30 years’ experience in PR, messaging, media strategy, and reputation. View (0) Answers

Ask a Question

Tyson Bertmaring

VP, Head of Partnership Success

Dyno Therapeutics

View (1) Answers

Ask a Question

Chris Meda

CCO, Director of Quality and Regulatory

AmplifiDx

Experienced CEO, President, CBO, COO roles in Dx & Rx View (0) Answers

Ask a Question

W. Henry Yaeger

CFO and COO

Plowshare Therapies

Rare-disease gene therapy CFO, Yale MBA, board leader, founder, investor, and fundraiser who turns complexity into clarity and results. View (0) Answers

Ask a Question

Want to see more? Login or Register for Free.

Disclosures

© 2026 BioTech Social Inc. (“BSI”). This website and related services are provided by BSI and BioTech Funding Portal LLC (“BFP”), a wholly owned subsidiary of BSI (collectively, “BioTech Social”). Certain regulated crowdfunding services and offerings available through this website are operated by BFP, while other content, features, and services may be provided, maintained, or supervised by BSI.

BFP is a FINRA member funding portal (FPRD #334156) registered with the U.S. Securities and Exchange Commission (“SEC”). Through BFP, eligible issuers may conduct offerings pursuant to Regulation Crowdfunding, and persons 18 years of age or older may review and invest in such offerings.

Offerings conducted by life science companies are subject to industry-specific risks, including but not limited to regulatory approval and clearance risk, clinical and development risk, intellectual property risk, commercialization risk, manufacturing and supply chain risk, and capital formation risk. Please review the applicable offering materials for additional information.

Investment offerings are speculative, illiquid, and involve a high degree of risk, including the possible loss of an investor's entire investment. Past performance of any security, company, project, management team, or technology is not indicative of future results.

Neither BFP nor BSI provides investment advice, recommendations, or suitability determinations. Neither BFP nor BSI provides tax, accounting, legal, or regulatory advice. Investors must make their own investment decisions and conduct their own due diligence prior to investing. The content contained herein does not constitute a solicitation of an offer to buy or sell any security.

By using this website, you agree to be bound by our Terms of Use, Privacy Policy, and Electronic Consent. Please review these carefully before using the website.

Hide Disclosure